Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products > 57 > 

57-52-3

Products Categories

Basic Information
CAS No.: 57-52-3
Name: BIS(TRIETHYLTIN)SULFATE
Molecular Structure:
Molecular Structure of 57-52-3 (BIS(TRIETHYLTIN)SULFATE)
Formula: C12H30 O4 S Sn2
Molecular Weight: 507.854
Synonyms: 4,6-Dioxa-5-thia-3,7-distannanonane,3,3,7,7-tetraethyl-, 5,5-dioxide (9CI); Bis(triethyltin) sulfate (6CI); Stannane,triethylhydroxy-, sulfate (2:1) (8CI); Tin, sulfatobis[triethyl- (7CI);Triethylhydroxytin sulfate; Triethyltin sulfate
Density: g/cm3
Melting Point: >300°C
Boiling Point: °Cat760mmHg
Flash Point: °C
Appearance: yellow amorphous powder
Hazard Symbols: A poison by ingestion. TWA 0.1 mg(Sn)/m3; STEL 0.2 mg(Sn)/m3 (skin).
Risk Codes: R36/37/38
Safety: Poison by ingestion, intraperitoneal, subcutaneous, intravenous, and parenteral routes. See also TIN COMPOUNDS and SULFATES. When heated to decomposition it emits toxic fumes of SOx.

Analytical Methods:

   

For occupational chemical analysis use NIOSH: Organotin Compounds 5504.

PSA: 60.98000
LogP: 5.35560
Related products
Hot Products
  • Display:default sort

    New supplier

  • Total:0 Page 0 of 0
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 57-52-3

Chemistry

IUPAC Name: bis(Triethylstannyl) sulfate
Synonyms of Bis(triethyltin) sulfate (CAS NO.57-52-3): Triaethylzinnsulfat ; Triethylhydroxystannane sulfate (2:1) ; Triethylhydroxytin sulfate ; Triethylstannium hydrogen sulfate ; Triethyltin sulfate ; Triethyltin sulphate ; 3,3,7,7-Tetraethyl-4,6-dioxa-5-thia-3,7-distannanonane 5,5-dioxide ; 4,6-Dioxa-5-thia-3,7-distannanonane, 3,3,7,7-tetraethyl-, 5,5-dioxide ; 4,6-Dioxa-5-thia-3,7-distannanonane, 3,3,7,7-tetraethyl-, 5,5-dioxide (9CI) ; Stannane, triethylhydroxy-, sulfate (2:1) (8CI) ; Tin, triethyl-, sulphate
InChI: InChI=1/6C2H5.H2O4S.2Sn/c6*1-2;1-5(2,3)4;;/h6*1H2,2H3;(H2,1,2,3,4);;/q;;;;;;;2*+1/p-2/rC12H30O4SSn2/c1-7-18(8-2,9-3)15-17(13,14)16-19(10-4,11-5)12-6/h7-12H2,1-6H3
InChIKey: BTVURVLQSDTSSS-QRAKGRNXAT
Std. InChI: InChI=1S/6C2H5.H2O4S.2Sn/c6*1-2;1-5(2,3)4;;/h6*1H2,2H3;(H2,1,2,3,4);;/q;;;;;;;2*+1/p-2
Std. InChIKey: BTVURVLQSDTSSS-UHFFFAOYSA-L
CAS NO: 57-52-3
Molecular Formula: C12H30O4SSn2
Molecular Weight: 507.8492
Molecular Structure :
EINECS: 200-335-4
H bond acceptors: 4
H bond donors: 0
Freely Rotating Bonds: 10
Polar Surface Area: 60.98 Å2
Flash Point: 182 °C
Enthalpy of Vaporization: 60.06 kJ/mol
Boiling Point: 377.3 °C at 760 mmHg
Vapour Pressure: 1.48E-05 mmHg at 25°C
Melting Point: >300°C

Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
bird - domestic LDLo intravenous 3mg/kg (3mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS		 British Journal of Pharmacology and Chemotherapy. Vol. 10, Pg. 16, 1955.
guinea pig LD50 intraperitoneal 3mg/kg (3mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

BEHAVIORAL: MUSCLE WEAKNESS		 British Journal of Industrial Medicine. Vol. 23, Pg. 222, 1966.
guinea pig LDLo oral 5mg/kg (5mg/kg)   British Journal of Pharmacology and Chemotherapy. Vol. 10, Pg. 16, 1955.
rabbit LDLo intraperitoneal 10mg/kg (10mg/kg)   British Journal of Pharmacology and Chemotherapy. Vol. 10, Pg. 16, 1955.
rabbit LDLo intravenous 3mg/kg (3mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION		 British Journal of Pharmacology and Chemotherapy. Vol. 10, Pg. 16, 1955.
rabbit LDLo oral 10mg/kg (10mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION		 British Journal of Pharmacology and Chemotherapy. Vol. 10, Pg. 16, 1955.
rat LD50 intraperitoneal 5700ug/kg (5.7mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION		 British Journal of Pharmacology and Chemotherapy. Vol. 10, Pg. 16, 1955.
rat LD50 intravenous 9050ug/kg (9.05mg/kg)   Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 242, Pg. 370, 1961.
rat LD50 parenteral 6mg/kg (6mg/kg) BRAIN AND COVERINGS: MENINGEAL CHANGES

BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: COMA		 Biochemical Journal. Vol. 61, Pg. 406, 1955.
rat LDLo oral 10mg/kg (10mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION		 British Journal of Pharmacology and Chemotherapy. Vol. 10, Pg. 16, 1955.
rat LDLo subcutaneous 25mg/kg (25mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION		 British Journal of Pharmacology and Chemotherapy. Vol. 10, Pg. 16, 1955.

Safety Profile

RIDADR: UN3146
HazardClass: 6.1
PackingGroup: III
Poison by ingestion, intraperitoneal, subcutaneous, intravenous, and parenteral routes. See also TIN COMPOUNDS and SULFATES. When Bis(triethyltin) sulfate (CAS NO.57-52-3) is heated to decomposition, it emits toxic fumes of SOx.

Standards and Recommendations

OSHA PEL: TWA 0.1 mg(Sn)/m3 (skin)
ACGIH TLV: TWA 0.1 mg(Sn)/m3; STEL 0.2 mg(Sn)/m3 (skin).
NIOSH REL: (Organotin Compounds) TWA 0.1 mg(Sn)/m3

Analytical Methods

For occupational chemical analysis use NIOSH: Organotin Compounds 5504.